Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health

Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.

The Conversation

2-in-1 shot for flu and COVID shows promise in advanced trial

2-in-1 shot for flu and COVID shows promise in advanced trial

The pharmaceutical company Moderna announced promising results from the ongoing trial of its new vaccine, mRNA-1083.

Moderna combi flu and Covid jab gives better protection, study finds

Moderna combi flu and Covid jab gives better protection, study finds

Clinical trials show two-in-one jab may bring about higher immune responses than separate inoculations

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Combined Covid and flu vaccine could be approved for use on NHS by next year

New vaccine could cut need for separate Covid and flu jabs

The Independent UK

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

The Independent UK

‘Extremely impressive’: melanoma jab trial results excite doctors

Vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician

The Guardian - UK

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

inkl

Read news from The Economist, FT, and more,
with one subscription

Scientists are testing mRNA vaccines to protect cows and people against bird flu

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

The Independent UK

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Coroner probes vaccine link to young woman's death

Coroner probes vaccine link to young woman's death

A Victorian coroner is investigating whether a woman's death from heart inflammation after receiving her third COVID-19 jab was due to the Moderna vaccine.

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

The Guardian - UK

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed -0.37%. Stocks Monday traded mildly lower on a +2.3 bp rise in the 10-year T-note...

Get all your
news in one place.

100’s of premium titles.
One news app.

Moderna (MRNA) Earnings Analysis: Buy or Watch for Gains?

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

Moderna (MRNA) and Biogen (BIIB) - Are There Upsides Left in These Biotech Stocks?

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience. So, let’s analyze the upside potential of popular biotech stocks Biogen (BIIB) and Moderna (MRNA).

New mRNA 'cancer vaccine' trial launches in UK

The first U.K. patient has received a dose of "cancer vaccine" in a new trial.

Moderna (MRNA) vs. Exelixis (EXEL) - Which Biotech Stock Is Worth Buying?

The biotech industry is poised for long-term growth, supported by the advancements in personalized medicine and integration with information technology. While leading biotech stocks Moderna (MRNA) and Exelixis (EXEL) should benefit from the industry tailwinds, let us predict which stock is worth buying.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Moderna's COVID Vaccine Sales Exceed Expectations in 2023!

In a stunning achievement, Moderna recently announced that their preliminary COVID vaccine sales for 2023 have met their target. This is fantastic news for...

Florida Surgeon General's Claims on COVID Vaccines Debunked as Nonsense

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

The Conversation

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Independent UK

Covid jabs could be sold on the high street like flu vaccine

Boots and Superdrug have confirmed they are looking at ways to sell Covid vaccines from their high street stores

FDA Spots Control Irregularities in Moderna's US Plant

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

People

Mangeet Kaur BounsMangeet

Charles Swanton

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Cancer Research UK

KFF Health News

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

339,540 stories

131,098 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play